RNA Analysis/Transcriptomics Market by Application & Technology - 2019

MarketsandMarkets Presents

RNA Analysis/ Transcriptomics Market worth $3,773.0 Million by 2019 http://www.marketsandmarkets.com/Market-Reports/trancriptomics-market240344576.html

According to the new market research report the report "RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019", published by MarketsandMarkets, the global Transcriptomics Market is estimated to be worth $1985.5 Million by the end of 2014 and is expected to reach $3,773.0 Million by 2019, at a CAGR of 13.7% from 2014 to 2019.

Browse 217 Market Data Tables 20 Figures 300 pages and in-depth TOC on "RNA Analysis/Trancriptomics Market" http://www.marketsandmarkets.com/Market-Reports/trancriptomics-market240344576.html Early buyers will receive 10% customization on this report.

http://www.marketsandmarkets.com/Market-Reports/trancriptomics-market-240344576.html

There is increasing demand for personalized medicines and continuous improvements in healthcare infrastructures which drives the growth of drug discovery and research. This has given a thrust to the demand for transcriptomic technologies which are widely used for the drug discovery and life science research. Moreover, the increasing number of pharmaceutical and biotechnology companies in Asia-Pacific region has opened new growth avenues for transcriptomics in the emerging markets. However, the higher initial investment cost hampers the growth of this market due to the reluctance of researchers to adopt the new technologies. Moreover, the dearth of skilled professionals and efficient bioinformatics tools for data analysis can inhibit the growth of Transcriptomics Market to a certain extent.

Buy Now: http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=240344576 In this report, the Transcriptomics Market is segmented on the basis of different types of technologies, applications, end-users, and geographies. This report also discusses the key market drivers, restraints, opportunities, and challenges. The global Transcriptomics Market is estimated to be worth $1985.5 Million by the end of 2014 and is expected to reach $3,773.0 Million by 2019, at a CAGR of 13.7% from 2014 to 2019. http://www.marketsandmarkets.com/Market-Reports/trancriptomics-market-240344576.html

In 2013, North America region holds the majors hare in the global transcriptomics market, followed by Europe and Asia-Pacific. The major share of the North American region is primarily attributed to the presence and expansion of major pharmaceutical and biotechnology companies in this region, especially in the U.S. Similarly, the increasing adoption of transcriptomics in drug discovery and clinical diagnostics has driven the growth of North American transcriptomics market. On the other hand, with the increasing number of biotechnology companies in Asia-Pacific region and thereby the rising research and development activities, the Transcriptomics Market in Asia-Pacific region is expected to grow at the highest rate during the forecast period.

Get PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=240344576 The prominent players in the market are Affymetrix Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), GE Healthcare (U.S.), Illumina Inc. (U.S.), Qiagen N.V. (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Sigma Aldrich (U.S.), Fluidigm Corporation (U.S.), and Thermofisher Scientific Inc. (U.S.).

http://www.marketsandmarkets.com/Market-Reports/trancriptomics-market-240344576.html

About MarketsandMarkets MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

http://www.marketsandmarkets.com/Market-Reports/trancriptomics-market-240344576.html

Contact Us Mr. Rohan North - Dominion Plaza, 17304 Preston Road, Suite 800, Dallas, TX 75252 Tel: +1-888-6006-441 Email: sales@marketsandmarkets.com MarketsandMarkets Blog http://www.marketsandmarkets.com http://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets